Name
Telliskivi Perearstikeskus OÜ
Registry code
11314753
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
10.11.2006 (17)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86211 - Provision of general medical treatment
463 235 €
27 225 €
6%
2 473 €
(estimate is approximate)
45 397 €
6
Submitted
No tax arrears
60%
30%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Urve Prits 30.11.1952 (71) | 100% - 2 556.00 EUR | Board member | Direct ownership | Founder |
| Karmen Palts 03.01.1976 (48) | - | - | - | Founder |
| 2019 30.06.2020 | 2020 12.08.2021 | 2021 30.06.2022 | 2022 27.06.2023 | 2023 18.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 363 611 € | 321 786 € | 370 257 € | 418 609 € | 463 235 € |
| Net profit (loss) for the period | 11 896 € | 15 840 € | 35 977 € | 53 347 € | 27 225 € |
| Profit Margin | 3% | 5% | 10% | 13% | 6% |
| Current Assets | 51 180 € | 49 891 € | 76 680 € | 94 462 € | 79 169 € |
| Fixed Assets | 8 137 € | 8 243 € | 7 014 € | 12 274 € | 10 535 € |
| Total Assets | 59 317 € | 58 134 € | 83 694 € | 106 736 € | 89 704 € |
| Current Liabilities | 32 009 € | 32 986 € | 37 569 € | 38 564 € | 44 307 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 27 308 € | 25 148 € | 46 125 € | 68 172 € | 45 397 € |
| Employees | 7 | 5 | 5 | 5 | 6 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 27 132.65 € | 28 365.28 € | 10 |
| 2023 Q4 | - | 25 512.97 € | 26 594.44 € | 9 |
| 2023 Q3 | - | 34 104.95 € | 24 488.9 € | 8 |
| 2023 Q2 | - | 20 180.24 € | 20 892.07 € | 7 |
| 2023 Q1 | - | 22 103.93 € | 22 832.24 € | 7 |
| 2022 Q4 | - | 17 922.37 € | 18 546.95 € | 7 |
| 2022 Q3 | - | 25 739.2 € | 20 317.3 € | 6 |
| 2022 Q2 | - | 17 711.74 € | 18 289.68 € | 6 |
| 2022 Q1 | - | 23 222.41 € | 24 064.57 € | 6 |
| 2021 Q4 | - | 17 038.38 € | 17 619.53 € | 6 |
| 2021 Q3 | - | 21 507.17 € | 19 971.79 € | 6 |
| 2021 Q2 | - | 17 942.65 € | 18 847.3 € | 6 |
| 2021 Q1 | - | 21 525.34 € | 19 365.26 € | 6 |
| 2020 Q4 | - | 16 307.06 € | 17 223.44 € | 6 |
| 2020 Q3 | - | 19 123.38 € | 18 133 € | 6 |
| 2020 Q2 | - | 14 763.7 € | 15 706.12 € | 6 |
| 2020 Q1 | - | 20 779.28 € | 19 747.3 € | 6 |
